10 DOC INT ACCT QUIZ 1
1 Page

10 DOC INT ACCT QUIZ 1

Course Number: ACCT 1234, Spring 2010

College/University: DeVry Bellevue

Word Count: 185

Rating:

Document Preview

(TCO A) On January 1, 2010, Korsak, Inc. established a stock appreciation rights plan for its executives. It entitled them to receive cash at any time during the next four years for the difference between the market price of its common stock and a pre-established price of $20 on 60,000 SARs. Current market prices of the stock are as follows: Compensation expense relating to the plan is to be recorded over a...

Unformatted Document Excerpt
Coursehero >> Washington >> DeVry Bellevue >> ACCT 1234

Course Hero has millions of student submitted documents similar to the one
below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.

Course Hero has millions of student submitted documents similar to the one below including study guides, practice problems, reference materials, practice exams, textbook help and tutor support.

A) (TCO On January 1, 2010, Korsak, Inc. established a stock appreciation rights plan for its executives. It entitled them to receive cash at any time during the next four years for the difference between the market price of its common stock and a pre-established price of $20 on 60,000 SARs. Current market prices of the stock are as follows: Compensation expense relating to the plan is to be recorded over a four-year period beginning January 1, 2010. What amount of compensation expense should Korsak recognize for the year ended December 31, 2011? Your Answer: $0 $30,000 CORRECT ANSWER $300,000 $150,000 Instructor Explanation: ($30 $20)X 60,000 X .5 = $300,000 $300,000 $270,000 = $30,000. Chapter 16 Points 0 Received: of 4 5. Question: (TCO A) Foyle, Inc., had 560,000 shares of common stock issued and outstanding at December 31, 2010. On July 1, 2011, an additional 40,000 shares of common stock were issued for cash. Foyle also had unexercised stock options to purchase 32,000 shares of common stock at $15 per share outstanding at the beginning and end of 2011. The average market price of Foyle's common stock was $20 during 2011. What is the number of shares that should be used in computing diluted earnings per share for the year ended December 31, 2011? Your Answer: 580,000 588,000 CORRECT 608,000 612,000 Instructor Explanation: 560,000 + (40,000 X 6/12) + [32,000 (32,000 X $15 $20)] = 588,000. Chapter 16.

Find millions of documents on Course Hero - Study Guides, Lecture Notes, Reference Materials, Practice Exams and more. Course Hero has millions of course specific materials providing students with the best way to expand their education.

Below is a small sample set of documents:

DeVry Bellevue - ACCT - 1234
Financial Reporting Problem: p.790; Procter & Gamble Company A) What is the par or stated value of P & GS preferred stock? P&Gs preferred stock has a stated value of $1 per share. As per information on the consolidated balance sheet page 219B) What is th
DeVry Bellevue - ACCT - 1234
International Reporting Case Sepracor, Inc Financial Statements under U.S. GAAP Account Current Liabilities Convertible Debt Total Liabilities Stockholders Equity Net Income 2007(000) $ 554,114 $ 648,020 $1,228,313 $ 176,413 $ 58,333A. Compute the follow
Arizona - ENG - GNG 1105
GNG1105 BSuggested exercises: week 13 September 2010 Maintopics:Summationofforcesatapoint(2D).NewtonsFirstLaws 2.422.472.572.68
Texas Woman's University - BUS - 5243
Name: _Roketa Tanner & Lisa Dang_ Date: 9/22/2010 1. Proper risk-return management means that A) the firm should take as few risks as possible. B) consistent with the objectives of the firm, an appropriate trade-off between risk and return should be deter
Berkeley - SOCIAL SCI - 101
A formal analysis of cultural evolution by replacementJing Xu (jing.xu@berkeley.edu) Florencia Reali (oreali@berkeley.edu) Thomas L. Grifths (tom grifths@berkeley.edu)Department of Psychology, 3210 Tolman Hall Berkeley, CA 94720 USA AbstractSocial psyc
Wyoming - ZOO - 4125
The CNS and Afferent Pathways (Chapter 10)Ill give a short history, and then: 1. Review of expected prior knowledge 2. Protection of CNS 3. Basic structure and functional components of the brain 4. Language 5. Contralateral control 6. Cerebral lateraliza
Wyoming - PHCY - 6100
9/6/20101 234567Current Good Compounding and Manufacturing Practices Standards for cGMP n Established by FDA n Domestic and foreign n Definitions found on pg 69 n n cGMP Overview n Organization and Personnel n Buildings and Facilities n Equipment n
Wyoming - PHCY - 6100
9/12/2010Drugs seldom administered alone They are part of a formulation Non-medicinal agents Pharmaceutical & Formulation Considerations Jodi Johnson Pharm ingredients or excipients thicken suspend etc Solubilize, thicken, suspend, etcAmount of drug to
Wyoming - PHCY - 6100
University of WyomingPHCY 6100DOSAGE FORM DESIGN Part 2: Biopharmaceutical and pharmacokinetic considerations 1) Biopharmaceutics: relationship between physical, chemical and biological characteristics of drugs, dosage forms and drug action. DRUG Dissol
Wyoming - PHCY - 6100
PHCY6100TeixeiraIntroductiontoDrugsandPharmacy 1. DRUG(medicinalagent)&DISEASES 2. TheheritageofPharmacy: a. PharmacistorApothecary(wiseman,priest,magician:)preparationanddispensingofdrugs 3. HistoryofDrugTherapy: a. Eberspapyrus:egyptians;16thcenturyB
Wyoming - PHCY - 6100
PHCY6100 LectureOutlineNewDrugDevelopmentandApprovalProcess 1. Discoveryofanewdrug a. Randomly b. Manyyearsoftirelesspursuit c. throughtargetedscreening d. molecularmodificationormechanismbaseddrugdesign) 2. Sourcesofnewdrugs a. Botanical i. plantextra
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
University of WyomingPHCY 6100Solid dosage formsFor oral use: powders, granules, capsules, tablets, lozenges, controlledrelease forms. b) For non-oral use: pellets or inserts, vaginal tablets, powders for topical use or inhalation. c) Preferred form to
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
Wyoming - PHCY - 6100
University of WyomingPHCY 6100Solid Dosage Forms: TABLETS1.Def. Solid dosage forms prepared by compression or molding of powdered/granulateddrugs and with the aid of suitable pharmaceutical excipients.2.Characteristics:a) Most frequently prescribe
Wyoming - PHCY - 6100
Capsules Canbecoloredwithdyesoropaque(titaniumdioxide) Moisture1316% Highermoisture:absorbedbycapsbecomedistortedandloserigidshape Verylowhumidity(highdryness):moisturelostbecomebrittleandcrumble Packagewithdesiccanttoavoidexcessortolowerthehumidity Gela
Wyoming - PHCY - 6100
University of WyomingPHCY 6100Solid Dosage Forms: CAPSULES1.Def. Solid dosage forms in which unit-doses of powder, semisolid, or liquid drugs areenclosed within a hard or soft gelatin envelope or shell.2.UsesA)As unit-doseB)As pre-measured medi
Wyoming - PHCY - 6100
UNIVERSITY OF WYOMINGSchool of PharmacyCOURSE SYLLABUSPHCY 6100 DOSE FORM DESIGNFall 2010Instructor Information:Instructor: M. Glaucia Teixeira [Tesh-ir-ah], PhD - Assoc. Professor of PharmaceuticsPhone: (307) 766-2690E-mail: glaucia@uwyo.eduWebs
Pima CC - PHCY - 6101
PHCY 6101Practical Aspects of Dosage Form DesignFall 2010 LAB PacketSchool of Pharmacy University of WyomingInstructor: M. Glaucia TeixeiraDose Form LabPHCY 6101-2010ContentsCourse Schedule. iii LABORATORY 1 . 1 INTRODUCTION TO LABORATORY . 1 Safe
Pima CC - PHCY - 6101
UNIVERSITY OF WYOMINGSchool of PharmacyCOURSE SYLLABUS PHCY 6101 PRACTICAL ASPECTS OF DOSAGE FORM DESIGN Fall 2010Instructor Information: Instructor: M. Glaucia Teixeira [Tesh-ir-ah], PhD - Assoc. Professor of Pharmaceutics. Phone: (307) 766-2690 E-mai
Pima CC - PHCY - 6101
PHCY 6101-LABFall 2010LABORATORY 1INTRODUCTION TO LABORATORYSafety in the laboratory Please take 5 minutes and review the safety rules listed below. The instructor will show the location of and demonstrate the use of safety supplies within the labor
Pima CC - PHCY - 6101
PHCY 6101- Dose Form LabFall 2010LABORATORY 2PHARMACEUTICAL MEASUREMENTSObjectives Introduction to the use of prescription balance class III (formerly class A) Learn how to determine the sensitivity requirement of a prescription balance Practice the u
Pima CC - PHCY - 6101
PHCY 6101- Dose Form LabFall 2010LABORATORY 3POWDERS & GRANULESObjectives Appreciate the versatility of powders and granules when used per se in therapeutics and in the preparation of other dosage forms. Learn to prepare a bulk powder for the medicina
Pima CC - PHCY - 6101
PHCY 6101Dose Form LABGRADINGOFLABEXERCISESThe neat appearance of the label on a compounded product and the clarity of the directions to the patient are as important as the container and the compounding of the prescription. As far as the patient is con
Pima CC - PHCY - 6101
PHCY 6101LAB GRADING RUBRIC: Balance, time, GLP (40 points)Lab#_Date:_Balancecleaning(5points)Student *Cleaning levels: chemicals on balance pan (-2 pt); chemicals on balance body (-2 pt); chemicals on bench (- 1 pt)*CleaninglevelPoints earnedNo
Pima CC - PHCY - 6106
UNIVERSITY OF WYOMINGSchool of PharmacyCOURSE SYLLABUS PHCY 6106 PHARMACEUTICAL CALCULATIONS Fall 2010Instructor Information: Instructor: M. Glaucia Teixeira [Tesh-ir-ah], PhD - Assoc. Professor of Pharmaceutics Phone: (307) 766-2690 E-mail: glaucia@uw
Pima CC - PHCY - 6106
Pima CC - PHCY - 6106
Pima CC - PHCY - 6106
Pima CC - PHCY - 6106
Wyoming - ZOO - 4125
Learning and Memory (see Chapter 10, pp296-298) 1. What is learning? 2. Memory? - types of memory 3. Neural changes 4. How is memory stored? 4. Long- term potentiation 5. Alzheimers Disease1. What do we mean by learning? Acquisition of information or ski
Wyoming - ZOO - 4125
4125 Integrative Physiology Study guide for Memory and Learning 1. What is the definition of:learning; associative- and non-associative- learning; memory; declarative- and procedural- memory. 2. Describe Hebbs Cell Assembly. b. what factors could hinder r
Wyoming - ZOO - 4125
Sensory Physiology see Chapter 11 We have discussed the anatomy/function of the brain and spinal cord, and the generation and propagation of electrical/chemical signals Now look at perception of sensory information . 1a.General properties of Sensory Recep
Wyoming - ZOO - 4125
Integrative Physiology Zoo 4125/5125 Fall 2010 Sensory Physiology Principles Objectives List Be able to describe the generation and propagation of Action Potentials, and chemical transmission at a synapse. (see 3115 notes and/or Review lecture) From the R
Wyoming - ZOO - 4125
4125 Integrative Physiology Sleep Study Guide 1. List the components of the polysomnograph. 2. List the 5 stages of sleep. 3. Describe how homeostatic pressure and circadian rhythm affect our ability to sleep. b. Define ultradian rhythm and hypnogram and
Wyoming - ZOO - 4125
Integrative Physiology ZOO4125/5125Fall 2010CNS and Afferent Pathways Study Guide and Objectives List Overall Aim: to describe the structure and function of the CNS, and to describe how it is protected. 1. List the 4 main functions of the Nervous System
Wyoming - ZOO - 4125
Special Senses: The Ear and The Eye 1.The anatomy of the ear 2. Sound transmission through the ear 3. Signal transduction in the cochlear duct 4. The Vestibular SystemSpecial Senses The ear is the sense organ for two special senses: hearing and equilibri
Wyoming - ZOO - 4125
Retention of Knowledge QuizIntegrative Physiology Zoo 4125/5125NAME: MAJOR: PAST PHYSIOLOGY TAKEN AT (Name of Institution): PAST COURSE TAKEN WHEN (Year):1. Name the organelle responsible for the production of ATP. Mitochondria 2. How do steroids get i
Wyoming - ZOO - 4125
Sensory PathwaysI will quickly review the following: 1. Functional components of a neuron 2. Generation of Graded Potentials 3. Generation of Action Potentials 4. Chemical transmission at a synapse I will introduce the following concepts: 5. Temporal sum
Wyoming - ZOO - 4125
Sleep and its Disorders (Chapter 10, pp293-294)1. How do we record sleep? 2. Stages of sleep 3. What makes us fall asleep? 4 . How does sleep change with age? 5. Theories of sleep 6. Arousal/Sleep systems and the roles of neurotransmitters For interest w
Wyoming - ZOO - 4125
ZOO 4125 Integrative Physiology Fall 2010 Study Guide for Special Senses: Vision, Hearing, Vestibular System 1. Define the components of the eye 2. Describe the 3 layers of the retina 3. Define the ratio of rods to cones in the retina 4. Describe the comp
Wyoming - ZOO - 4125
Study tips for Human Systems Physiology 3115. The important thing is to study Physiology in bite-sized pieces. I recommend studying 45 minutes every day, and/or 5 points per night from the study guide. It depends on the complexity of the task. Here are my
Wyoming - ZOO - 4125
THE EYE 1. Anatomy of the eye 2. The Retina 3. Phototransduction 4. Neural Processing 5. Neural pathwaysOuter Layer Sclera connective tissue Cornea allows light to enter Middle Layer Choroid absorbs light Ciliary Body attaches lens Lens focuses light on
Wyoming - ZOO - 4125
TheAdrenal1. 1. 1. 2. 3. Anatomyofthecortexanditshormones Biosynthesisoftheadrenalsteroids CRHACTHcortisol ACTH(andMSH)andskincolor Pathologyoftheadrenal Nelsons Addisons Cushings CAH4. 5.Aldosterone RegulationofBloodPressureHypothalamoPituitaryAdren
Wyoming - ZOO - 4125
Wyoming - ZOO - 4125
E ndocr i nol ogy1. 2. 3. 4. 5. 6. Br i ef H i stor y What consti tutes an endocr i ne system? Endocr i ne Or gans Endocr i ne Pathways H or mone Pr oducti on Secr eti onA n Endocr i ne SystemA detai l ed under standi ng of an endocr i ne system wi l l
Wyoming - ZOO - 4125
Introduction to Endocrinology Overall aim: To achieve an integrative understanding of the endocrine system and to understand how information is transmitted within the endocrine system. Specific objectives: 1. Define a hormone 2. Define the 7 stages of wha
Wyoming - ZOO - 4125
The PinealOverall aim: To achieve an integrative understanding of the relationship between the biological clock (the suprachiasmatic nucleus) and the pineal gland and how the pineal hormone, melatonin, regulates daily (circadian) and seasonal (circannual
Wyoming - ZOO - 4125
Reproduction and Sexual DevelopmentStudy Objectives To define the oogenesis, follicular growth, seminiferous tubules, Leydig cells, Sertoli cells, granulosa cells, thecal cells, the SRY gene, the Wolffian duct, the Mullerian duct To describe role of PGF2
Wyoming - ZOO - 4125
ReproductionHypothalamopituitaryaxissimilarinmalesand females Males FSHandLHontestes Females FSHandLHonovary Ovulation LutealphaseMaleFemaleT h e R e p ro d uc tive Ne uro e nd o c rine S y s te m GnRH neuron in the preoptic area A 2000 GnRH neurons
Wyoming - ZOO - 4125
Sexual DifferentiationBackground Development of genitalia and brain from an undifferentiated prototype How does the male develop? Different developmental outcomes Congenital Adrenal Hyperplasia (CAH) Androgen Insensitivity SyndromeBRAI NDick S waab & S
Wyoming - ZOO - 4125
The AdrenalStudy Objectives To draw the hypothalamo-pituitary-adrenal (HPA) axis To define the zona glomerulosa, zona fasiculata and zona reticularis, To describe the structure and function of the adrenal cortex, secretory pattern of cortisol and its imp
Wyoming - ZOO - 4125
ThePinealGland,Rhythms&Melatonin1. 1. 2. 3. 4. 5. 6. Historyandanatomyofthepineal Thesynthesisandsecretionofmelatonin Transmissionoflightinformationtothepineal TheSCNandactivityrhythms MelatoninentrainstheSCN Roleinotherphysiologicalprocesses Roleinseaso
Wyoming - ZOO - 4125
Biology, 7e (Campbell)Chapter 9: Cellular Respiration: Harvesting Chemical EnergyChapter Questions1) What is the term for metabolic pathways that release stored energy by breaking down complex molecules? A) anabolic pathways B) catabolic pathways C) fe
Wyoming - ZOO - 4125
Thyroid Gland Study Objectives To describe the synthesis and release of thyroid hormones (T3 and T4), transport of thyroid hormone in plasmaTo draw a model of the hypothalamo-pituitary-thyroid axis. functioning thyroid follicleTo explain thyroid hormo